Clinical Evidence Several clinical trials and studies underscore the cardiovascular benefits of GLP-1 receptor agonists: SUSTAIN-6 Trial : This pivotal trial demonstrated a significant reduction in major adverse cardiovascular events (MACE) among patients treated with GLP-1 compared to placebo
Understanding the multifaceted benefits of GLP-1 receptor agonists can help healthcare providers and patients make informed decisions about their use, ultimately leading to better health and quality of life.
That exceeds anything achieved by semaglutide or tirzepatide in comparable time frames
If you are in possession of suspected counterfeit product, you are highly encouraged to: Report suspicious Ozempic product with lot number PAR1229 and the above information or other suspected Novo Nordisk counterfeit products, or if patients need additional help determining if a Novo Nordisk product is counterfeit, please call Novo Nordisk customer care at 1-800-727-6500 Monday through Friday from 8:30 AM to 6:00 PM EST
10.1155/2017/7542540 [DOI] [PMC free article] [PubMed] [Google Scholar] Jiang H., Tian X., Guo Y., Duan W., Bu H., Li C